Ocrevus 300 mg (Ocrelizumab 300 mg / 10 ml) by Roche.
Indications: Relapsing forms of multiple sclerosis and early primary progressive MS.
Administration: Intravenous: 2 × 300 mg infusions 2 weeks apart, then 600 mg every 6 months.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Roche |
| Active ingredient | Ocrelizumab 300 mg / 10 ml — humanised anti-CD20 monoclonal antibody. |
| Strength & pack | 1 vial of 10 ml. |
| Form | Concentrate for solution for infusion |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |